حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
United Laboratories International Holdings Ltd
3933The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules. It also provides intermediate products, such as 6-aminopenicillanic acid, tert-octylammonium clavulanate, anhydrous sodium carbonate sterile, and penicillin G potassium first crystal. In addition, the company manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products, as well as offers management services. It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. Address: 6 Fuk Wang Street, Yuen Long, Hong Kong
Analytics
سعر الهدف في وول ستريت
90.93 HKDنسبة السعر إلى الأرباح
5.8613العائد الربحي
7.47 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 3933
تحليلات الأرباح 3933
نمو الأرباح على مدى 5 سنوات
363 %النمو المستمر
5 سنينمعدل الدفع 5 سنوات في المتوسط
20 %تاريخ الأرباح 3933
تقييم الأسهم 3933
المالية 3933
نتائج | 2019 | ديناميات |